Table 3 Logistic regression analysis assessing the relationships of SIRI with LV hypertrophy, LV impaired systolic function and left atrial enlargement

LV hypertrophy

Q1

1(Reference)

-

1(Reference)

-

1(Reference)

-

Q2

0.67(0.30–1.48)

0.319

0.85(0.37–1.96)

0.700

0.82(0.35–1.91)

0.645

Q3

1.00(0.48–2.09)

1.000

1.30(0.59–2.86)

0.510

1.20(0.54–2.68)

0.651

Q4

1.71(0.86–3.38)

0.126

2.58(1.21–5.52)

0.014

2.39(1.11–5.13)

0.026

LV impaired systolic function

Q1

1(Reference)

1(Reference)

1(Reference)

-

Q2

0.85(0.28–2.62)

0.775

1.02(0.32–3.19)

0.980

0.92(0.28–2.97)

0.886

Q3

0.85(0.28–2.62)

0.775

1.14(0.36–3.59)

0.826

0.92(0.29–2.99)

0.895

Q4

3.72(1.51–9.14)

0.004

5.61(2.15–14.60)

< 0.001

4.78(1.79–12.78)

0.002

Left atrial enlargement

Q1

1(Reference)

-

1(Reference)

-

1(Reference)

-

Q2

1.21(0.70–2.09)

0.488

1.14(0.64–2.03)

0.662

0.94(0.49–1.80)

0.859

Q3

1.59(0.92–2.76)

0.096

1.39(0.77–2.50)

0.272

1.13(0.59–2.18)

0.711

Q4

3.20(1.79–5.74)

< 0.001

2.60(1.39–4.88)

0.003

2.20(1.10–4.39)

0.025